Substituted carbonucleoside derivatives useful as anticancer agents
申请人:Pfizer Inc.
公开号:US10220037B2
公开(公告)日:2019-03-05
Compounds of the general formula):
processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.
通式)的化合物:
这些化合物的制备工艺、含有这些化合物的组合物以及这些化合物的用途。
Substituted ureas and methods of making and using same
申请人:MEBIAS DISCOVERY, INC.
公开号:US10683283B2
公开(公告)日:2020-06-16
The invention relates to substituted ureas, and compositions comprising the same, which in certain embodiments are useful for treating and/or preventing pain in a subject in need thereof.
SUBSTITUTED CARBONUCLEOSIDE DERIVATIVES USEFUL AS ANTICANCER AGENTS
申请人:Pfizer Inc.
公开号:EP3464249A1
公开(公告)日:2019-04-10
Substituted Ureas and Methods of Making and Using Same
申请人:Mebias Discovery, Inc.
公开号:US20200308155A1
公开(公告)日:2020-10-01
The invention relates to substituted ureas, and compositions comprising the same, which in certain embodiments are useful for treating and/or preventing pain in a subject in need thereof.